Video After The Jump
NASHVILLE, Tenn. (WKRN) — Brandy Parker-McFadden sits in her Vanderbilt hospital bed, unable to stand.
“Our youngest is like – are you ever going to walk again? We just reassure him this is extremely rare.”
The mother of three received her second Pfizer COVID shot on April 16. Hours later, an unusual sensation started in her legs.
“Then it turned into a horrible neck pain, and it just kept getting worse and worse,” recounted Brandy.
Her husband James knew something was terribly wrong. “She was screaming in pain. She is one that is pretty stoic. That’s what created the sense of urgency.”
James rushed Brandy to the emergency room at Vanderbilt, and then the unimaginable happened.
“I woke up. I can’t move my arms. I can’t move my legs. So, he’s freaking out. The doctors are panicking,” Brandy recalled.
“I’m holding her hand, and her hand is limp throughout the whole thing while she’s screaming in pain,” remembers James, “And all the test results are coming back negative.”
Ten days later, Brandy is able to move her arms again and wiggle her toes. She will now undergo intensive physical therapy, hoping to walk again.
“I’m going to fight. I’m a fighter,” Brandy said with a determined look.
Brandy wants to be very clear; she isn’t saying don’t get your vaccine. She wants people to be aware of the signs and speak up if they don’t feel well.
“If you’re hesitant, I tell people to call your doctors because it is extremely rare.”
News 2 reached out to Pfizer. The company released the following statement:
“We take adverse events that are potentially associated with our COVID-19 vaccine, BNT162b2, very seriously. We closely monitor all such events and collect relevant information to share with global regulatory authorities. At this time, our ongoing review has not identified any safety signals with paralysis and the Pfizer-BioNTech Covid-19 vaccine.
To date, more than 200* million people around the world have been vaccinated with our vaccine. It is important to note that serious adverse events that are unrelated to the vaccine are unfortunately likely to occur at a similar rate as they would in the general population.”